Mindray(SZ:300760) Sou Hu Cai Jing·2025-07-07 03:42Core Viewpoint - The recent positive news regarding high-end medical devices has led to increased attention and investment in the medical device sector, particularly in the medical device ETF fund (159797) which experienced fluctuations in trading volume and price [1][6]. Group 1: Policy Developments - The National Medical Products Administration (NMPA) has announced measures to optimize the regulatory framework for high-end medical devices, focusing on special approval processes and classification principles to support innovation [1][4]. - New policies emphasize the importance of global innovation and the establishment of a comprehensive regulatory and quality assurance system for high-end medical devices [4][5]. - Specific areas of focus for innovation include medical robots, advanced medical imaging equipment, AI medical devices, and new biomaterials [4][5]. Group 2: Market Reactions - The medical device ETF fund (159797) saw a slight decline of 0.54% after an initial increase of nearly 2%, indicating volatility in investor sentiment despite positive news [1][3]. - Major stocks within the ETF, such as Hotgen Biotech and Mindray Medical, experienced declines, while a few others like United Imaging Healthcare saw slight gains [3]. Group 3: Future Outlook - The medical device sector is expected to recover as procurement activities resume, with government policies potentially boosting market demand for medical equipment in 2025 [5]. - The issuance of long-term bonds and local special bonds is anticipated to provide financial support for hospital procurement of medical devices, contributing to industry growth [5].